Literature DB >> 7442298

Flow dependence of first-order uptake of substances by heterogeneous perfused organs.

L Bass.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7442298     DOI： 10.1016/0022-5193(80)90012-0

Source DB:  PubMed          Journal:  J Theor Biol        ISSN： 0022-5193            Impact factor:   2.691


× No keyword cloud information.
  9 in total

1.  Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Authors:  M S Roberts; J D Donaldson; D Jackett
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

2.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

3.  Influence of unbound fraction and perfusate flow rate on taurocholate elimination by perfused rat liver: applicability of three distributed models.

Authors:  D J Morgan
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

5.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

6.  Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.

Authors:  R H Smallwood; D J Morgan; G W Mihaly; D B Jones; R A Smallwood
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

7.  A nonlinear physiologic pharmacokinetic model: I. Steady-state.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

8.  Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patients.

Authors:  P J Robinson; L Bass; S M Pond; M S Roberts; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

9.  The pharmacokinetics of the interstitial space in humans.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2003-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.